Article Details
Retrieved on: 2025-03-12 17:02:26
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The second generation of CD40L blockers included some biologics that were not monoclonal antibodies. Most of these reduced thrombosis risk, but ...
Article found on: www.theglobeandmail.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here